Telpha-Trio

Composition: Telmisartan 40 mg + Cilnidipine 10 mg + Chlorthalidone 12.5 mg

Telpha Trio is a powerful triple-drug combination used for the treatment of severe and resistant hypertension. This formulation combines the vascular protection of Telmisartan, smooth BP reduction of Cilnidipine, and the fluid-reducing action of Chlorthalidone. It is highly effective in patients requiring aggressive BP control.

Uses:

• Severe and resistant hypertension

• Patients not controlled with dual therapy

• Reduces heart attack and stroke risk

• Manages fluid retention with strong BP control

Side Effects:

• Dizziness

• Frequent urination

• Low potassium

• Fatigue

• Mild ankle swelling

Other Details:

• Once-daily dosing

• Electrolyte and kidney monitoring required

• Best suited for high-risk hypertensive patients

• Avoid dehydration